The use of bioresonance therapy in the treatment of hyperprolactinemia

AUTHORS : Kasimova G.Sh. | Ermina E.L.

RELEVANT UNIVERSITIES : Homeopathic Center, Kirov, Russia

YEAR : 2004 | Category : Case Study

One of the poorly understood conditions in clinical practice is hyperprolactinemia. Recently, the number of patients with such the diagnosis has increased many times. Our Center has experience in treating this condition. An increase in the level of prolactin in the blood may be a consequence of microadenomas of the pituitary gland, however, in our observations, this was more often associated with functional disorders in the body, affecting the hypothalamo-pituitary system.

The causes of such disorders can be called acute or chronic stress, heavy physical exertion, underweight, abortion, miscarriages, previous surgeries, neuroinfections, etc. Hyperprolactinemia may be associated with hypothyroidism, polycystic ovary disease, and chronic renal failure, suggesting a holistic approach to treating this condition rather than simple drug management of a single symptom.

Increasingly, hyperprolactinemia is the result of long-term use of certain pharmacological drugs, such as: tranquilizers, antipsychotics, antidepressants, narcotic analgesics, oral contraceptives, etc. Therefore, at the initial appointment with persons with hyperprolactinemia, we recommend that you carefully find out the history and clarify which drugs are being taken by the patient at the present time.

Neuroregulation of prolactin secretion (PRL) is multifactorial and is under the control of the hypothalamus. The main neurotransmitter that inhibits PRL is dopamine. More recently, it was found that the level of PRL in the blood serum does not always determine the clinical picture of the disease. In some patients with high BPD, the menstrual cycle may be intact or absent from galactorrhea (a key symptom of hyperprolactinemia).

This is due to the biochemical heterogeneity of circulating PRL in the blood (Bulatov A.A. et al., 1995, Ian S.S.K., 1998). Treatment of hyperprolactemia at the present stage consists in the appointment of such drugs as: parlodel (bromocriptine), cabergoline, norprolac, abergin. These drugs have a number of serious adverse reactions and require longterm use (6 months or more).